港股异动|首创置业涨逾4%中期纯利同比增约61%
格隆汇8月19日丨首创置业(2868.HK)现报2.69港元,涨4.67%,暂成交189万港元,最新总市值81.45亿港元。首创置业上周五(16日)晚间发布中期业绩公告称,期内营业收入104.76亿元(人民币,下同),较去年同期增加约47%;营业利润21.8亿元,同比增长约42%;归属于母公司股东的净利润11.87亿元,较去年增长约61%;基本每股收益为人民币0.30元(2018年同期为0.19元),同比增长约58%;不派中期息。此外,期内实现签约金额405.4亿元,同比增长12.4%,其中三大核心城市实现签约金额360亿元,占比约90%。据悉,公司今年全年的签约目标为800亿元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.